Article 3 in the Series: What Pharmacies Need to Know About State Board of Pharmacy Inspections
In this series, we began by examining the authority of state boards of pharmacy. We then surveyed the different types of inspections that may occur and the steps a pharmacy should take to prepare before an inspector arrives. This article turns to the inspection itself: what the inspectors are trained to evaluate and the operational deficiencies that most frequently result in findings.
Understanding what inspectors look for is not a matter of guesswork. Many state boards publish inspection checklists and inspection guides that map directly to the areas an inspector will review. Pharmacies that align their compliance processes with these published standards are better positioned to identify and correct potential deficiencies before they result in adverse findings.
Licenses, Permits, and Credentials
Pharmacy inspections typically include a review of fundamental licensing, permitting, and credentialing requirements. Inspectors may confirm that the pharmacy’s license or permit is current and properly displayed. They may also verify that the pharmacy’s DEA registration is current. They may then confirm that all pharmacists and technicians on duty are wearing appropriate name tags identifying their role. Inspectors will confirm that individual practitioners hold current licenses and have satisfied continuing education requirements. Deficiencies such as an expired registration or a technician badge that fails to distinguish its wearer from a pharmacist are among the most commonly cited findings across jurisdictions.
Some boards also publish document request forms listing the records inspectors most frequently request. These reflect the practical reality that an inspector begins by focusing on the basics.
Controlled Substance Records and Accountability
Controlled substance oversight is a central focus of many pharmacy inspections. Inspectors evaluate whether controlled substances are accurately recorded on appropriate forms. They confirm that Schedule I and II records are maintained separately from all other pharmacy records, as required by federal law. Inspectors may also confirm that the pharmacy has conducted its required biennial inventory and can produce an accurate count of all controlled substances on hand.
Beyond recordkeeping, inspectors may look for evidence that the pharmacy has systems to identify suspect prescriptions and verify their legitimacy before filling them. Pharmacies lacking documented protocols for handling questionable prescriptions expose themselves to findings that can escalate beyond the inspection itself. As an example, California’s Board of Pharmacy reported that controlled substance inventory reconciliation was among the top corrections on routine inspections in fiscal year 2024/25.
Drug Storage, Security, and Expired Medications
Inspectors assess the physical environment of the pharmacy, including drug storage conditions, refrigerator and freezer temperatures, security measures, and the presence of expired medications in stock. Inadequate security remains among the most commonly cited deficiencies, including access-control failures and inadequate computer security.
Temperature management is another important area of inspection. Refrigerators must be maintained at appropriate temperatures and logged accordingly. Non-medication items must not be stored alongside medications. Operational standards and security were among the top correction categories on California routine inspections during fiscal year 2024/25.
Prescription Records, Labeling, and Patient Consultation
An inspector may review prescription records, labeling practices, and patient counseling procedures with particular care. All medications must be properly labeled and comply with applicable federal and state requirements. California’s patient-centered labeling regulation was among the top corrections for non-chain pharmacies during fiscal year 2024/25.
Patient consultation is another area of scrutiny. California’s Board of Pharmacy reported that, during fiscal year 2024/25, 160 routine inspections revealed patient consultation issues. Sixty-eight inspections found that the pharmacy was not giving written notice of consultation rights on delivered or mail-order prescriptions, while 83 found that the written notice did not meet regulatory requirements. Many of the remainder found that consultation was not provided at all.
Staffing, Supervision, and Technician Compliance
Inspectors evaluate pharmacist-to-technician ratios and supervision practices. They assess whether technicians are properly identified and perform only authorized tasks. Common deficiencies may include technicians not wearing identifying name tags or performing duties without direct pharmacist supervision as required by state law.
Policies, Procedures, and Required Documentation
A pharmacy’s policies and procedures manual is not simply a binder on a shelf. It is an operational document that inspectors expect to see reflected in daily practice. Florida, for example, requires that pharmacy permit applications include procedures addressing controlled substance dispensing based on fraudulent representations or invalid practitioner-patient relationships. Inspectors may also verify that staff have reviewed the manual and understand its protocols.
Beyond the existence of written policies, inspectors look for evidence that those policies are consistently followed. Missing signatures, incomplete records, and undocumented corrective actions suggest a compliance program that exists on paper but is not consistently implemented. Self-assessment forms, quality assurance policies, medication error reports, and board correspondence should all be current and accessible.
Compounding-Specific Areas of Scrutiny
Pharmacies engaged in sterile or non-sterile compounding face additional scrutiny. Areas of review may include facility cleanliness, design standards, master formula records, beyond-use date assignments, and quality assurance. Inspectors evaluate whether the pharmacy maintains complete compounding logs, and whether it has conducted annual process validation of aseptic technique.
In Ohio, compounding pharmacies may face additional inspection by a Board Specialist. Common deficiencies include incomplete log entries, improper integration of sterile and non-sterile areas, and non-compliance with beyond-use date documentation. These findings are particularly significant because compounding deficiencies implicate patient safety in ways that can trigger accelerated enforcement action.
Common Pharmacy Inspection Deficiencies
Across jurisdictions, certain categories of deficiencies appear with striking regularity. California’s Board of Pharmacy data from fiscal year 2024/25 identifies the top corrections separately for chain and non-chain pharmacies. For chain pharmacies, top corrections included operational standards and security, pharmacists administering vaccines, pharmacist-in-charge self-assessment, and duty to consult. For non-chain pharmacies, they included controlled substance inventory reconciliation, duty to consult, operational standards and security, and patient-centered labels. Ohio and Missouri organize similar checklists around licensing, HIPAA compliance, drug storage, controlled substances, dispensing practices, and patient counseling.
The common thread across many jurisdictions is that the most frequent deficiencies are not obscure regulatory technicalities. They are fundamental operational requirements that every pharmacy should be continuously addressing.
What This Means for Pharmacy Owners and Pharmacists-in-Charge
For pharmacy owners and pharmacists-in-charge, the lesson is clear: the inspector’s checklist should be your checklist. Boards publish inspection guides, self-assessment forms, and checklists precisely so that pharmacies can measure themselves against the same standards reviewed during inspections. Pharmacies that use these tools proactively convert the inspection from a threat into a confirmation of work already done.
The pharmacies most vulnerable to adverse findings are not necessarily those with complex operations, but those that allow documentation gaps to accumulate, treat policies as static documents, and respond to compliance obligations reactively rather than proactively.
Looking Ahead in the Pharmacy Inspection Process
In the next article in this series, we will examine what happens after a pharmacy inspection concludes. We will cover inspection reports, corrective action requirements, and how findings can escalate to adverse actions. Understanding the post-inspection process is essential for any pharmacy that receives an inspection report identifying deficiencies.
The bottom line is that inspection readiness should be an ongoing compliance function, not an exercise that begins when an inspector arrives. Many of the deficiencies commonly identified during pharmacy inspections involve core operational requirements that can be monitored and addressed through regular internal reviews. A pharmacy that treats applicable board inspection guides and published standards as internal compliance benchmarks is better positioned to identify problems early, document corrective action, and respond effectively when an inspection occurs.
How Frier Levitt Can Help
Frier Levitt advises pharmacies on state Board of Pharmacy compliance, inspection readiness, and responses to identified deficiencies. Our attorneys can help pharmacy owners and pharmacists-in-charge assess compliance risks, prepare for inspections, and address issues that arise during or after an inspection. Contact us to learn how we can help your pharmacy prepare for and navigate the inspection process.
Read Article 1 in the Series: What Is a State Board of Pharmacy and Why Does It Inspect You?
Read Article 2 in the Series: Types of State Board of Pharmacy Inspections and How to Prepare for Them
